Results

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	RMSD	Seq. Identity (%)	HETATM
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	1uk4	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 7	TYR B 154 ASP B 155 ASP B 153 LYS B 102	1.75A	18.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	2acf	REPLICASE POLYPROTEIN 1AB (SARS-COV Tor2)	4 / 7	ASP D 349 ASP D 352 LYS A 273 HIS A 268	1.70A	15.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	2k87	NSP3 OF REPLICASE POLYPROTEIN 1A (SARSr)	4 / 7	ASP A 115 ASP A 115 ASP A 115 LYS A 112	1.45A	12.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	4 / 7	ASP B 272 TYR B 88 ASP B 87 LYS B 276	1.74A	21.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	MET B 851 ASP B 849 LYS B 715 HIS B1040	1.64A	18.98	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	6cs0	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 7	ASP B 191 ASP A 415 ASP A 414 LYS B 190	1.49A	19.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	6nur	NSP12 (SARSr-CoV)	4 / 7	TYR A 831 ASP A 833 LYS A 438 HIS A 439	1.78A	20.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	7btf	NSP12 (SARS-CoV-2)	4 / 7	TYR A 826 ASP A 824 ASP A 825 HIS A 928	1.72A	19.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	7btf	NSP12 NSP8 (SARS-CoV-2)	4 / 7	ASP A 523 TYR B 71 MET B 70 LYS A 369	1.61A	19.94	None